The 19 patients meeting the Amsterdam and Bethesda criteria were subjected to molecular analysis of MMR genes (MLH1, MSH2, MSH6, and PMS2) and the EPCAM gene, while the remaining 11 patients underwent NGS analysis of 25 genes associated with major hereditary cancer predisposition syndromes, including LS. This evidence concerns the gene MLH1 and Leigh syndrome.